Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03901 |
| Species: | Homo sapiens |
| Position : | chr20:46120155-46120433 |
| Year: | 2015 |
| Title: | Correlation of the osteoarthritis susceptibility variants that map to chromosome 20q13 with an expression quantitative trait locus operating on NCOA3 and with functional variation at the polymorphism rs116855380. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chondrosarcoma |
| PMID: | 26211391 |
| MONDO: | MONDO:0008977 |
| Tissue: | cartilage tissue |
| Tissue Ontology ID: | UBERON:0002418 |
| Cell Source: | SW1353 |
| CVCL ID: | CVCL_0543 |
| Cell Type: | chondrosarcoma cell |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| Low Throughput Method: | Luciferase Reporter Assay; EMSA; RT-RT-qPCR; Western blot, siRNA-mediated gene knockdown |
| Target gene : | NCOA3 |
| TF name : | NA |
| Regulatory State : | Repressed |
| GeneName | Pathway Name | Source | Gene Number |
|---|